Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart



Skip to content